Dr. Weyer and colleagues conducted a longitudinal study on 48 adult Pima Indians--a group considered at high risk for developing both diabetes and obesity. At study entry, all participants had normal glucose tolerance. Each year, the investigators measured body composition, glucose tolerance, insulin action, oxidative versus nonoxidative disposal of glucose, insulin secretory capacity, and endogenous glucose production rate in each subject.
Over the course of the study 17 persons progressed from normal glucose tolerance to impaired glucose tolerance, then to diabetes; these were called "progressors." The remaining 31 subjects continued to have normal glucose tolerance ("non-progressors"). In a comparison of the two groups, the investigators found that
* Progressors gained more weight (both fat and lean mass) than did non-progressors;
* Fasting insulin levels increased steadily as subjects progressed from normal glucose tolerance to diabetes--suggesting that insulin secretion becomes progressively abnormal as insulin resistance increases; and
* Progressors were ultimately unable to compensate for increased insulin resistance by increasing their insulin output; however, non-progressors did increase insulin output. These findings support previous studies concluding that diabetes results from diminished early insulin secretion plus defects in the patient's ability to respond to insulin.
Persons at high risk for this steady downslide into type 2 diabetes might benefit from aggressive preventive measures, including diet and weight loss--but identifying such individuals has been difficult. The usual research methods for measuring insulin resistance and insulin secretory ability are not usable in routine clinical practice. However, Dr. Marian Rewers reported that the oral glucose tolerance test, combined with fasting and 2-hour insulin levels, is almost as accurate for predicting diabetes risk as research tools that are extremely sensitive but clinically impractical.
In the Insulin Resistance and Atherosclerosis Study, Dr. Rewers and colleagues conducted a statistical analysis comparing the power of easily measured clinical parameters, such as body mass index and fasting blood glucose, to the results of oral glucose tolerance tests and rapid-sampling intravenous glucose tolerance test (IVGTT) in 1,500 subjects at different stages of glucose tolerance. They found that IVGTT was, as expected, the most reliable at predicting future development of type 2 diabetes--but that oral glucose tolerance testing and fasting blood glucose values were only slightly less accurate.
STEPS IN DEVELOPMENT OF TYPE 2 DIABETES
1. Normal glucose tolerance
2. Defects in glucose synthesis and storage; development of insulin insensitivity
3. Increase in fasting insulin levels
4. Pancreatic [beta]-cell dysfunction, leading to defective insulin secretion
5. Defects in suppression of endogenous glucose production (insulin resistance in the liver)